The impact of acquired immunodeficiency in a patientwith b-cell chronic lymphocytic leukemia on the course ofcoronavirus disease (Covid-19): a case report
Chronic lymphocytic leukemia (CLL) is a lymphoproliferative disorder that affects the bone marrow, lymph nodes, and spleen, and is associated with certain complications. One of the complications of CLL is acquired immunodeficiency, leading to a predisposition for prolonged respiratory viral and bacterial infections. This publication presents a clinical case of a prolonged and severe course of COVID-19 in a patient with CLL, who was successfully treated with immunoglobulin replacement therapy.
Authors
- L. K. Benkovska (ORCID: https://orcid.org/0000-0003-3436-3128)
- O. M. Kostiukevych (ORCID: https://orcid.org/0000-0003-3499-080X)
- Oleksandr V. Naumenko
- Mariia A Trypilka
Publication Details
- Journal
- Wiadomości Lekarskie
- Published
- 2024-12-23
- DOI
- https://doi.org/10.36740/wlek/197124
- Primary Topic
- Chronic Lymphocytic Leukemia Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00